INT279799

Context Info Confidence 0.00 First Reported 2009 Last Reported 2009 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 2 Disease Relevance 1.77 Pain Relevance 0.12

plasma membrane (ATP6V0A2, ERBB3) endosome (ATP6V0A2) transmembrane transport (ATP6V0A2) cytoplasm (ATP6V0A2) extracellular space (ERBB3) signal transduction (ERBB3)

Anatomy Link Frequency MCF-7 1 MDA-MB-231 1 ATP6V0A2 (Homo sapiens) ERBB3 (Homo sapiens)

Pain Link Frequency Relevance Heat palliative 2 60.84 complementary and alternative medicine 6 47.60 withdrawal 2 5.00

Disease Link Frequency Relevance Heat Breast Cancer 96 100.00 Cancer 26 96.00 Apoptosis 90 88.24 Cirrhosis 2 69.08 Colon Cancer 2 68.24 Liver Cancer 2 68.00 Immunotherapy Of Cancer 4 31.60 Disease 10 26.60 Endometriosis (extended) 2 19.84 Death 24 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Accordingly, the first objective of this study was to characterize the effects of TJ-41 on hormone sensitive and insensitive breast cancer cell lines (MCF-7 and MDA-MB-231, resp.).

TJ-41 Regulation (effects) of MDA-MB-231 in MDA-MB-231 associated with breast cancer

1) Confidence 0.00 Published 2009 Journal Journal of Oncology Section Body Doc Link PMC2730474 Disease Relevance 0.89 Pain Relevance 0.06

Accordingly, the first objective of this study was to characterize the effects of TJ-41 on hormone sensitive and insensitive breast cancer cell lines (MCF-7 and MDA-MB-231, resp.).

TJ-41 Regulation (effects) of MDA-MB-231 in MCF-7 associated with breast cancer

2) Confidence 0.00 Published 2009 Journal Journal of Oncology Section Body Doc Link PMC2730474 Disease Relevance 0.89 Pain Relevance 0.06

General Comments

This test has worked.